Shanrong Biotechnology's total assets for Q were $190.55K, a decrease of -12.65% from the previous quarter. SRBT total liabilities were $4.17M for the fiscal quarter, a 1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.